Lauren Bowling, APRN
Psychiatric/Mental Health · Russellville, ARNPI 1629788013
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 36 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 8 manufacturers, the largest accounting for just 23.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $452, 3.5 times the $130 reported in 2023. That places this record below the midpoint for psychiatric/mental health clinicians in AR, where the typical reported total is $800.
Across 36 payments — averaging $21.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$178
- Johnson & Johnson$176
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$169
- Axsome Therapeutics, Inc.$132
- Otsuka America Pharmaceutical, Inc.$47
- Vanda Pharmaceuticals Inc.$20
- plus $36 from 2 others
What the payments were for
- Food & beverage$758100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 12 | $178 |
| Johnson & Johnson | 5 | $176 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 9 | $169 |
| Axsome Therapeutics, Inc. | 5 | $132 |
| Otsuka America Pharmaceutical, Inc. | 2 | $47 |
| Vanda Pharmaceuticals Inc. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Lundbeck LLC | 1 | $16 |
How this compares
$758 in reported general payments places this provider in the 45th percentile of 359 psychiatric/mental health providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trazodone Hcl | 23 | $282 |
| Escitalopram Oxalate | 19 | $207 |
| Sertraline Hcl | 20 | $150 |
| Fluoxetine Hcl | 12 | $143 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Russellville
- Stephanie BohannonFayetteville$32K
- Michael BelinSherwood$30K
- Sarah RamseySearcy$12K
- Mallori LevengoodPine Bluff$11K
- Jennifer PenneFayetteville$11K
- Stephanie ParishSearcy$9K
- Elizabeth HardyTexarkana$8K
- Tammy HawkinsJonesboro$8K
- Cara MeckfesselLittle Rock$8K
- Sakinah ShawHot Springs$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.